Cargando…
Genetic Analysis in a Taiwanese Cohort of 750 Index Patients with Clinically Diagnosed Familial Hypercholesterolemia
Aim: Familial hypercholesterolemia (FH) is underdiagnosed in most countries. The genetic heterogeneity of FH requires an algorithm to efficiently integrate genetic testing into clinical practice. We aimed to report the spectrum of genetic mutations from patients with clinically diagnosed FH in Taiwa...
Autores principales: | Huang, Chin-Chou, Niu, Dau-Ming, Charng, Min-Ji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135666/ https://www.ncbi.nlm.nih.gov/pubmed/33994402 http://dx.doi.org/10.5551/jat.62773 |
Ejemplares similares
-
Genetic Diagnosis of Familial Hypercholesterolemia in Asia
por: Huang, Chin-Chou, et al.
Publicado: (2020) -
Clinical Evaluation Of Evolocumab For The Treatment Of Homozygous Familial Hypercholesterolemia In Chinese Patients
por: Huang, Chin-Chou, et al.
Publicado: (2019) -
Characterization of familial hypercholesterolemia in Taiwanese ischemic stroke patients
por: Tung, Hsin, et al.
Publicado: (2021) -
Genetic Analysis of Japanese Children Clinically Diagnosed with Familial Hypercholesterolemia
por: Nagahara, Keiko, et al.
Publicado: (2022) -
Prevalence of genetically defined familial hypercholesterolemia and the impact on acute myocardial infarction in Taiwanese population: A hospital-based study
por: Chen, Yen-Ju, et al.
Publicado: (2022)